• 25961 Citations
  • 64 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Letter
2020
2019

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

Sparano, J. A., Sep 26 2019, In : The New England journal of medicine. 381, 13, p. 1290-1291 2 p.

Research output: Contribution to journalLetter

Letters

Sparano, J. A., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalLetter

TAILORx: Questions answered, lessons learned, and remaining knowledge gaps

Sparano, J. A. & Gray, R., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1841-1842 2 p.

Research output: Contribution to journalLetter

3 Scopus citations
2018

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

Anampa, J., Haque, T., Murakhovskaya, I., Wang, Y., Bachiashvili, K., Papazoglu, C., Pradhan, K., Steidl, U. G., Sparano, J. A. & Verma, A., Feb 28 2018, In : Haematologica. 103, 3, p. e98-e102

Research output: Contribution to journalLetter

1 Scopus citations
2016

A 21-Gene Expression Assay in Breast Cancer

Sparano, J. A., Apr 7 2016, In : The New England journal of medicine. 374, 14, p. 1387 1 p.

Research output: Contribution to journalLetter

4 Scopus citations
2010

Reply to K. Dunleavy et al

Chadburn, A., Noy, A., Lee, J. Y., Hyjek, E., Banham, A. H., Sparano, J. A., Bhatia, K. & Cesarman, E., Jun 1 2010, In : Journal of Clinical Oncology. 28, 16, p. e261-e262

Research output: Contribution to journalLetter

5 Scopus citations

Reply to T. Grenader et al

Sparano, J. A., Apr 20 2010, In : Journal of Clinical Oncology. 28, 12, p. e195-e196

Research output: Contribution to journalLetter

Reply to T.J. Smith et al

Sparano, J. A., Mar 10 2010, In : Journal of Clinical Oncology. 28, 8, p. e129-e130

Research output: Contribution to journalLetter

2009

Letter to the Editor

Goldstein, L. J. & Sparano, J. A., Mar 10 2009, In : Journal of Clinical Oncology. 27, 8, p. 1338-1339 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Reply to J.M. Guinebretiere and L. Arnould et al

Badve, S. S., Baehner, F. L., Gray, R. P., Childs, B. H., Maddala, T., Liu, M. L., Rowley, S. C., Shak, S., Perez, E. A., Shulman, L. J., Martino, S., Davidson, N. E., Sledge, G. W., Goldstein, L. J. & Sparano, J. A., Jun 1 2009, In : Journal of Clinical Oncology. 27, 16, p. 2734-2735 2 p.

Research output: Contribution to journalLetter

2008

The author replies

Sparano, J. A., Jul 17 2008, In : New England Journal of Medicine. 359, 3, p. 310-311 2 p.

Research output: Contribution to journalLetter

2005

In reply [11]

Sparano, J., Feb 20 2005, In : Journal of Clinical Oncology. 23, 6, p. 1329-1330 2 p.

Research output: Contribution to journalLetter

2003

Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection [4]

Spina, M., Sparano, J. A., Jaeger, U., Rossi, G. & Tirelli, U., Jan 3 2003, In : AIDS. 17, 1, p. 137-138 2 p.

Research output: Contribution to journalLetter

25 Scopus citations
1995

Estrogen Replacement Therapy in Breast Cancer Survivors

Cobleigh, M. A., Berris, R. F., Bush, T., Davidson, N. E., Robert, N. J., Sparano, J. A., Tormey, D. C. & Wood, W. C., Feb 1995, In : JAMA: The Journal of the American Medical Association. 273, 8, 1 p.

Research output: Contribution to journalLetter

2 Scopus citations
1990

Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer

Sparano, J. A. & Wiernik, P. H., Jan 1 1990, In : Journal of Clinical Oncology. 8, 5, p. 938-939 2 p.

Research output: Contribution to journalLetter

4 Scopus citations
1986

The acquired immunodeficiency syndrome and nonmenstrual toxic shock syndrome

Sparano, J. & Ferranti, E., Jan 1 1986, In : Annals of internal medicine. 105, 2, p. 300-301 2 p.

Research output: Contribution to journalLetter

8 Scopus citations